Avanos Medical, Inc. announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer. In this role, Scharfenberg will be responsible for leading the Avanos Compliance & Ethics (C&E) program, which operationalizes Avanos's commitment to ethical and legally compliant operations. In collaboration with senior management and the board of directors' Compliance Committee, she will define and implement the C&E program's strategic objectives and ensure that Avanos has effective controls in place to comply with the law and company policy and to foster an ethical culture. Scharfenberg's extensive background, including more than 20 years of experience in healthcare law, ethics and compliance, enterprise risk assessment, litigation, internal investigations and Lean methodology, make her uniquely qualified for this role at Avanos. Previously, Scharfenberg served as vice president and chief compliance officer for Cantel Medical Corporation, a leading provider of infection prevention products and services in the healthcare market. While at Cantel, she recast the existing compliance program as a proactive program with a Lean mindset scaled to size and risk, including modifications to the anti-bribery and training programs. Prior to that, Scharfenberg held various global leadership roles at Integra LifeSciences Corporation, a global provider of medical devices and implants for neurosurgery and orthopedic surgery.